Abstract Details

Title The New Alteplase (tPA) Package Insert: What Is the Potential Impact?

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 296

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Harn Shiue, PharmD (Mayo Clinic Arizona Hospital) PRESENTER	Dr. Shiue has nothing to disclose.
Karen C. Albright, DO, DO, PhD, MS, MPH (FDA)	Dr. Albright has nothing to disclose.
Kara A. Sands, MD (University of Alabama at Birmingham, Department of Neurology)	Dr. Sands has nothing to disclose.
	No disclosure on file
Michael J. Lyerly, MD, FAAN (University of Alabama At Birmingham)	Dr. Lyerly has nothing to disclose.
Toby I. Gropen, MD (University of Alabama At Birmingham)	Dr. Gropen has nothing to disclose.

��ɫ����